Suppr超能文献

[两种不同剂量罗库溴铵用于气管插管的肌动图和肌电图研究]

[Mechanomyographic and electromyographic studies of endotracheal intubation with 2 different rocuronium dosages].

作者信息

Hofmockel R, Benad G, Kabott A

机构信息

Klinik für Anästhesiologie und Intensivtherapie, Universität Rostock.

出版信息

Anaesthesiol Reanim. 1994;19(6):144-8.

PMID:7865062
Abstract

Rocuronium is a new, intermediate-acting, nondepolarizing relaxant with rapid onset of action leading to both good and very good intubation conditions. It was the aim of our study to investigate the onset of action, the intubation conditions and the course of relaxation using two different dosage regimes. Thirty consenting ASA 1 and 2 patients received either 0.6 mg/kg (2 x ED 95; group 1) or 0.06 mg/kg as priming dose followed by an intubating dose of 0.24 mg/kg rocuronium (group 2) four min later. Anaesthesia was induced with propofol (2 mg/kg) and alfentanil (0.02 mg/kg) and maintained with nitrous oxide/oxygen and propofol (6 to 8 mg/kg/h). Neuromuscular function was monitored mechanomyographically and electromyographically with TOF stimulation at the wrist every 10 seconds. Intubation conditions were determined using a semiquantitative score system, and times to 90% block (intubation time), maximum block (onset time) and recovery from neuromuscular blockade to 25%, 50%, 75% and 90% were calculated and comparisons were made between the corresponding results of the two groups. The intubation dose of 2 x ED 95 (group 1) was followed by a significantly shorter intubation time (39.1 +/- 9.6 sec.) than in group 2 with priming and an intubation dose of 0.24 mg/kg (50.7 +/- 11.0 sec). The intubation conditions showed no differences. In both groups they were good or very good. The clinical duration of action was significantly longer in group 1 (28.4 +/- 8.0 min) than in group 2 (14.8 +/- 2.5 min). It can be concluded that rocuronium which has shorter intubation times than atracurium and vecuronium is very useful for endotracheal intubation in both dosage regimes in long and very long lasting operations. Using the "priming principle" the patient has to be carefully controlled during priming time.

摘要

罗库溴铵是一种新型的中效非去极化肌松药,起效迅速,能产生良好和极佳的插管条件。本研究旨在使用两种不同的给药方案,研究其起效时间、插管条件及肌松过程。30例自愿参与的美国麻醉医师协会(ASA)分级为1级和2级的患者,分别接受0.6mg/kg(2倍ED95;第1组)或0.06mg/kg作为预注剂量,4分钟后再给予0.24mg/kg罗库溴铵的插管剂量(第2组)。麻醉诱导采用丙泊酚(2mg/kg)和阿芬太尼(0.02mg/kg),并以氧化亚氮/氧气和丙泊酚(6~8mg/kg/h)维持。每10秒通过刺激腕部的拇内收肌,用机械肌电图和肌电图监测神经肌肉功能。采用半定量评分系统确定插管条件,并计算达到90%阻滞的时间(插管时间)、最大阻滞时间(起效时间)以及从神经肌肉阻滞恢复到25%、50%、75%和90%的时间,对两组相应结果进行比较。第1组给予2倍ED95的插管剂量后,插管时间(39.1±9.6秒)明显短于第2组(预注加0.24mg/kg插管剂量,50.7±11.0秒)。插管条件无差异,两组均为良好或极佳。第1组的临床作用时间(28.4±8.0分钟)明显长于第2组(14.8±2.5分钟)。可以得出结论,罗库溴铵插管时间比阿曲库铵和维库溴铵短,在长时间和极长时间手术的两种给药方案中,对气管插管都非常有用。采用“预注原则”时,在预注期间必须对患者进行仔细监测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验